The Intellectual Property Institute of Canada (IPIC) and IP Osgoode are delighted to announce our 2017 Canadian writing challenge in intellectual property law.
As ratification stutters for the Comprehensive Economic and Trade Agreement (CETA), the much-maligned free-trade deal between Canada and the European Union, debate continues as to whether the Canadian intellectual property (IP) regime will provide adequate protection for innovative biologic medicines in relation to subsequent-entry biologics (SEBs). Biologic medicines are complex molecules derived from living organisms […]
Yes, it is apparently possible – Elsevier just did it. Elsevier is one of the largest science and medical publishers in the world. Prestigious journals, such as Cell and The Lancet, are amongst its products. Over the years, it has been the subject of a number of criticisms, including its pricing regime (see here, here […]
On September 14, the European Commission published draft legislation aimed at modernising the European copyright framework. To ensure the draft legislation delivers the best outcomes for all those affected by it, the Intellectual Property Office made a call for views on the costs and benefits of the proposed measures, and suggestions for how the language […]